BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 12817876)

  • 1. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
    Miettinen M; Lasota J
    Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
    Miettinen M; Sobin LH; Sarlomo-Rikala M
    Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
    Miettinen M; Majidi M; Lasota J
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
    Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
    Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal stromal tumours.
    Miettinen M; Sarlomo-Rikala M; Lasota J
    Ann Chir Gynaecol; 1998; 87(4):278-81. PubMed ID: 9891765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
    Miettinen M; Lasota J
    Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall.
    Lam MM; Corless CL; Goldblum JR; Heinrich MC; Downs-Kelly E; Rubin BP
    Int J Gynecol Pathol; 2006 Jul; 25(3):288-92. PubMed ID: 16810068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
    Demetri GD
    Semin Oncol; 2001 Oct; 28(5 Suppl 17):19-26. PubMed ID: 11740803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revision of gastrointestinal mesenchymal tumors.
    Sornmayura P; Howannapakorn J; Karnsombut P
    J Med Assoc Thai; 2009 Jan; 92(1):87-95. PubMed ID: 19260248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
    Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
    Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
    Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
    Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumor: an ultrastructural investigation on regional differences with considerations on their histogenesis.
    Min KW
    Ultrastruct Pathol; 2010 May; 34(3):174-88. PubMed ID: 20455665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
    Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
    J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.
    Rege TA; Wagner AJ; Corless CL; Heinrich MC; Hornick JL
    Am J Surg Pathol; 2011 Apr; 35(4):495-504. PubMed ID: 21358303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
    Lasota J; Miettinen M
    Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.
    Moskaluk CA; Tian Q; Marshall CR; Rumpel CA; Franquemont DW; Frierson HF
    Oncogene; 1999 Mar; 18(10):1897-902. PubMed ID: 10086344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of gastric stromal tumors.
    Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
    J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.